Introduction

Neil Love: Welcome to our webinar on the implications of new research findings in the management of end-to-mutrial cancer. Of course, we're talking about the two big trials just presented at the Society of Gynecologic Oncology and the Esmo meeting. As always, if you have any questions or cases you'd like to run by us, just type them into the chat room. We'll be back tomorrow at the same time of talking about new developments in bladder cancer,. specifically metastatic disease where there's so many options now.